Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4261]

AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple-negative breast cancers

AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple...

AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes

AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer...

AACR 2015: Black women found to have denser breast tissue than white women

AACR 2015: Black women found to have denser breast tissue than white women

AACR 2015: Antibody-drug conjugate shows early promise for patients with metastatic HER2-positive breast cancer

AACR 2015: Antibody-drug conjugate shows early promise for patients with metastatic HER2-positive breast cancer

AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER-positive breast cancer

AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER...

AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer patients

AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer...

AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive...

AACR 2015: Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some

AACR 2015: Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer...

AACR 2015: US breast cancer cases expected to increase by as much as 50 percent by 2030

AACR 2015: US breast cancer cases expected to increase by as much as 50 percent by 2030

AACR 2015: Extended overnight fasting may lead to reduced breast cancer risk

AACR 2015: Extended overnight fasting may lead to reduced breast cancer risk

More from ecancer